RESUMEN
The endothelial glycocalyx (eGC) plays a pivotal role in the physiology of the vasculature. By binding plasma proteins, the eGC forms the endothelial surface layer (ESL) which acts as an interface between bloodstream and endothelial cell surface. The functions of the eGC include mechanosensing of blood flow induced shear stress and thus flow dependent vasodilation. There are indications that levels of plasma sodium concentrations in the upper range of normal and beyond impair flow dependent regulation of blood pressure and may therefore increase the risk for hypertension. Substances, therefore, that prevent sodium induced endothelial dysfunction may be attractive for the treatment of cardiovascular disease. By means of combined atomic force-epifluorescence microscopy we studied the impact of the hawthorn (Crataegus spp.) extract WS 1442, a herbal therapeutic with unknown mechanism of action, on the mechanics of the ESL of ex vivo murine aortae. Furthermore, we measured the impact of WS 1442 on the sodium permeability of endothelial EA.hy 926 cell monolayer. The data show that (i) the ESL contributes by about 11% to the total endothelial barrier resistance for sodium and (ii) WS 1442 strengthens the ESL resistance for sodium up to about 45%. This mechanism may explain some of the vasoprotective actions of this herbal therapeutic.
Asunto(s)
Permeabilidad de la Membrana Celular/efectos de los fármacos , Crataegus/química , Células Endoteliales/citología , Flavonoides/farmacología , Nanopartículas/química , Extractos Vegetales/farmacología , Sodio/metabolismo , Animales , Bovinos , Línea Celular , Células Endoteliales/efectos de los fármacos , Células Endoteliales/metabolismo , Liasa de Heparina/farmacología , Humanos , Técnicas In Vitro , Microscopía de Fuerza Atómica , Microscopía Fluorescente , Modelos Biológicos , Propiedades de Superficie/efectos de los fármacosRESUMEN
Heparanase has been previously associated with the metastatic potential, inflammation, and angiogenesis of tumor cells. Heparanase activity has been detected by means of UV absorption, radiolabeled substrates, electrophoretic migration, and heparan sulfate affinity assays. However, those methods have proven to be somewhat problematic with regards to application to actual biological samples, the accessibility of the immobilized substrates, experimental sensitivity, and the separation of degraded products. Rather than focusing on heparanase activity, then, we have developed a rapid, alternative colorimetric heparinase assay, on the basis of the recent finding that sulfated disaccharides generated from heparin by bacterial heparinase exhibit biological properties comparable to those from heparan sulfate by mammalian heparanase. In this study, the concentrations of porcine heparin and bacterial heparinase I were determined using a Sigma Diagnostics Kit. Morus alba was selected as a candidate through this assay system, and an inhibitor, resveratrol, was purified from its methanol extract. Its anti-metastatic effects on the pulmonary metastasis of murine B16 melanoma cells were also evaluated. Our findings suggest that this assay may prove useful as a diagnostic tool for heparinase inhibition, as an alternative anti-metastatic target.
Asunto(s)
Antineoplásicos/farmacología , Inhibidores Enzimáticos/farmacología , Liasa de Heparina/análisis , Metástasis de la Neoplasia/tratamiento farmacológico , Extractos Vegetales/farmacología , Animales , Bioensayo , Línea Celular Tumoral , Colorimetría/métodos , Ensayos de Selección de Medicamentos Antitumorales , Inhibidores Enzimáticos/análisis , Femenino , Flavobacterium/enzimología , Heparina/análisis , Heparina/metabolismo , Liasa de Heparina/antagonistas & inhibidores , Mucosa Intestinal , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/patología , Neoplasias Pulmonares/secundario , Melanoma/tratamiento farmacológico , Melanoma/patología , Melanoma/secundario , Ratones , Ratones Endogámicos C57BL , Morus/química , Metástasis de la Neoplasia/patología , Organismos Libres de Patógenos EspecíficosRESUMEN
The mechanisms by which secretory phospholipase A2 (PLA2) exerts cellular effects are not fully understood. To elucidate these mechanisms, we systematically and quantitatively assessed the activities of human group IIA, V, and X PLA2s on originating and neighboring cells using orthogonal fluorogenic substrates in various mixed cell systems. When HEK293 cells stably expressing each of these PLA2s were mixed with non-transfected HEK293 cells, group V and X PLA2s showed strong transcellular lipolytic activity, whereas group IIA PLA2 exhibited much lower transcellular activity. The transcellular activity of group V PLA2 was highly dependent on the presence of cell surface heparan sulfate proteoglycans of acceptor cells. Activation of RBL-2H3 and DLD-1 cells that express endogenous group V PLA2 led to the secretion of group V PLA2 and its transcellular action on neighboring human neutrophils and eosinophils, respectively. Similarly, activation of human bronchial epithelial cells, BEAS-2B, caused large increases in arachidonic acid and leukotriene C4 release from neighboring human eosinophils. Collectively, these studies show that group V and X PLA2s can act transcellularly on mammalian cells and suggest that group V PLA2 released from neighboring cells may function in triggering the activation of inflammatory cells under physiological conditions.
Asunto(s)
Eicosanoides/metabolismo , Fosfolipasas A/metabolismo , Fosfolipasas A/fisiología , Animales , Ácido Araquidónico/metabolismo , Western Blotting , Encéfalo/metabolismo , Línea Celular , Línea Celular Tumoral , Membrana Celular/metabolismo , ADN Complementario/metabolismo , Eosinófilos/metabolismo , Epitelio/metabolismo , Fosfolipasas A2 Grupo II , Proteoglicanos de Heparán Sulfato/metabolismo , Liasa de Heparina/metabolismo , Humanos , Inflamación , Leucotrieno C4/metabolismo , Microscopía Confocal , Modelos Químicos , Neutrófilos/metabolismo , Fosfolipasas A2 , Fosfolípidos/metabolismo , Isoformas de Proteínas , Ratas , Espectrometría de Fluorescencia , Factores de Tiempo , TransfecciónAsunto(s)
Acremonium/química , Acremonium/metabolismo , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/farmacología , Liasa de Heparina/antagonistas & inhibidores , Hidroxibenzoatos/química , Hidroxibenzoatos/farmacología , Animales , Antineoplásicos/química , Antineoplásicos/aislamiento & purificación , Antineoplásicos/farmacología , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Ensayos de Selección de Medicamentos Antitumorales , Inhibidores Enzimáticos/aislamiento & purificación , Fermentación , Heparina/metabolismo , Hidroxibenzoatos/aislamiento & purificación , Concentración 50 Inhibidora , Espectroscopía de Resonancia Magnética , Melanoma/tratamiento farmacológico , Melanoma/patología , Ratones , Estructura Molecular , Invasividad Neoplásica , Células Tumorales CultivadasRESUMEN
Glycoproteins commercially available in multi-gram quantities, were used to prepare milligram amounts of neoglycoproteins. The glycoproteins bromelain and bovine gamma-globulin were proteolyzed to obtain glycopeptides or converted to a mixture of glycans through hydrazinolysis. The glycan mixture was structurally simplified by carbohydrate remodeling using exoglycosidases. Glycopeptides were biotinylated using N-hydroxysuccinimide activated-long chain biotin while glycoprotein-derived glycans were first reductively aminated with ammonium bicarbonate and then biotinylated. The resulting biotinylated carbohydrates were structurally characterized and then bound to streptavidin to afford neoglycoproteins. The peptidoglycan component of raw, unbleached heparin (an intermediate in the manufacture of heparin) was similarly biotinylated and bound to streptavidin to obtain milligram amounts of a heparin neoproteoglycan. The neoglycoconjugates prepared contain well defined glycan chains at specific locations on the streptavidin core and should be useful for the study of protein-carbohydrate interactions and affinity separations.
Asunto(s)
Bromelaínas/química , Proteoglicanos/química , gammaglobulinas/química , Animales , Biotinilación , Secuencia de Carbohidratos , Bovinos , Cromatografía en Agarosa , Liasa de Heparina/química , Espectroscopía de Resonancia Magnética , Datos de Secuencia Molecular , Proteoglicanos/aislamiento & purificación , Estreptavidina/químicaRESUMEN
We have examined the association of apoE with the extracellular matrix (ECM) of HepG2 cells. Comparison of ECM prepared by previously published methods demonstrated that cytochalasin B-prepared material yielded the highest endogenous apoE, representing 23.6% of that in cell monolayers. ECM prepared with EDTA or Triton X-100 exhibited decreased levels of apoE, 3 and 6%, respectively. ECM bound very low density lipoprotein poorly (5-6% of the monolayer capacity); however, these incubations dramatically increased the apoE content of the ECM. Heparinase or suramin decreased apoE of the ECM by 19.6 and 37.3%, respectively, suggesting association with heparin sulfate proteoglycans. EDTA or EGTA also displaced 35% of the apoE, suggesting a Ca2+-dependent association. Incubation with phosphatidylcholine vesicles (PCV) displaced 30% of the apoE, suggesting that lipid content affects association of apoE with the ECM. Data derived from sequential incubations with combinations of suramin, EGTA, and PCV were consistent with the presence of two distinct pools of apoE on the HepG2 ECM, one releasable with suramin and EGTA and the other releasable with lipids. Exogenously applied lipid-free apoE readily bound to the ECM; however, increasing the lipid content decreased its association. Lipid-free apoE could be equally displaced from the ECM with PCV or suramin. When lipid-free apoE adsorbed to microtiter wells was incubated with a triglyceride emulsion or palmitoyloleyl phosphatidylcholine micelles, the immunoreactivity of 3H1 (but not other antibodies), a monoclonal antibody against an epitope in the C-terminal domain of apoE, increased about 4-fold. In a similar manner, incubation of ECM with lipid dramatically increased the immunoreactivity of 3H1, indicating that apoE of the ECM exists in a lipid-poor form. Scatchard analysis demonstrated that the increased immunoreactivity was due to an increase in the number of antibody binding sites. In conclusion, the ECM contains two pools of lipid-poor apoE. One pool associates with the ECM through heparin sulfate proteoglycans- and Ca2+-dependent interactions. A second pool of apoE dissociates from the ECM upon lipidation. The lipid-sensitive pool of apoE may participate in secretion or efflux of lipids or in the capture of lipoproteins by providing the apoE needed for receptor-mediated uptake.
Asunto(s)
Apolipoproteínas E/metabolismo , Matriz Extracelular/química , Liasa de Heparina/metabolismo , Lípidos/farmacología , Anticuerpos Monoclonales/inmunología , Anticuerpos Monoclonales/farmacología , Apolipoproteínas E/análisis , Carcinoma Hepatocelular/química , Ácido Egtácico/farmacología , Emulsiones , Emulsiones Grasas Intravenosas/farmacología , Heparitina Sulfato/metabolismo , Humanos , Lipoproteínas/metabolismo , Fosfatidilcolinas/farmacología , Fosfolípidos , Unión Proteica/fisiología , Aceite de Cártamo , Aceite de Soja , Suramina/farmacología , Células Tumorales CultivadasRESUMEN
Using a macrophage cell line that constitutively expresses a human apolipoprotein E (apoE) cDNA, we have investigated the post-translational metabolism of endogenously produced apoE. Inhibition of lysosomal or cysteine proteases led to significant inhibition of apoE degradation but did not increase apoE secretion, indicating that cellular degradation is not limiting for apoE secretion in macrophages. Treatment of macrophages with inhibitors of proteoglycan synthesis (4-methylumbelliferyl-beta-D-xyloside) or sulfation (sodium chlorate) enhanced the release of apoE from cells and significantly attenuated the increase in secretion produced by incubation with phosphatidylcholine vesicles (PV). These observations suggested that a significant fraction of the apoE retained by cells (and released by incubation with PV) was associated with proteoglycans. Treatment of cells with exogenous heparinase led to a greater than 4-fold increase in apoE secretion and similarly attenuated the response to PV, suggesting that apoE was trapped in an extracellular proteoglycan matrix. This conclusion was confirmed in studies showing that PV could enhance the release of apoE from cells during an incubation at 4 degrees C, but this enhanced release was abolished in proteoglycan-depleted cells. Incubation with lactoferrin at 4 or 37 degrees C produced a similar decrement in cellular apoE, again indicating the existence of a cell surface pool of apoE. Pulse-chase studies showed that the apoE trapped in the proteoglycan matrix was susceptible to rapid cellular degradation such that net synthesis of apoE (secreted plus cell-associated) was increased significantly in proteoglycan-depleted cells compared with control cells as early as 45 min during a chase period.
Asunto(s)
Apolipoproteínas E/biosíntesis , Macrófagos/metabolismo , Proteoglicanos/metabolismo , Apolipoproteínas E/genética , Apolipoproteínas E/metabolismo , Línea Celular , Membrana Celular/metabolismo , ADN Complementario/genética , Liasa de Heparina , Humanos , Lactoferrina/farmacología , Macrófagos/efectos de los fármacos , Modelos Biológicos , Fosfatidilcolinas/farmacología , Polisacárido Liasas/farmacología , Inhibidores de Proteasas/farmacología , Fracciones Subcelulares/metabolismo , TransfecciónRESUMEN
Heparin biosynthesis involves a critical early step of N-deacetylation which is inhibited by the short chain fatty acid n-butyrate. Such inhibition causes mast cells to produce heparins with high affinity for antithrombin (AT). We have cultured endothelial cells in media supplemented with short chain fatty acids and have found that isobutyric, propionic and valeric acids cause significant increases in endothelial binding of AT measured by flow cytometry, but n-butyric acid was the most effective fatty acid to increase AT binding. Such binding,was heparan sulfate-dependent, for it was decreased significantly by pre-treatment of the cells with heparinase. These findings suggest that inhibition of N-deacetylation in heparan biosynthesis affects sulfation and results in the distribution of negative charges and conformation changes within the heparan domain that binds AT to endothelial plasma membranes. These changes also were associated with up-regulation of the intercellular adhesion molecule-1, which is a marker of endothelial activation.
Asunto(s)
Antitrombina III/metabolismo , Butiratos/farmacología , Endotelio Vascular/metabolismo , Heparitina Sulfato/metabolismo , Anticoagulantes/farmacología , Antitrombina III/efectos de los fármacos , Ácido Butírico , Células Cultivadas , Endotelio Vascular/citología , Endotelio Vascular/efectos de los fármacos , Heparina/farmacología , Liasa de Heparina , Humanos , Molécula 1 de Adhesión Intercelular/efectos de los fármacos , Molécula 1 de Adhesión Intercelular/metabolismo , Polisacárido Liasas/farmacologíaRESUMEN
The purpose of this study was to determine the biochemical and molecular characteristics of mucin synthesized by cystic fibrosis cells (CFPAC-1), a pancreatic cancer cell line derived from a patient with cystic fibrosis, and pancreatic cancer (SW-1990) cell lines. High molecular weight glycoproteins (HMG) were quantified by [3H]-glucosamine labeling and chromatography on sepharose CL-4B. Mucin gene expression was determined by using cDNA probes for 2 distinct intestinal mucins (MUC2 and MUC3) and one stomach mucin (MUC1). The specific mucin core epitopes were confirmed by immunoblots using antibodies that recognize T, Tn, sialosyl Tn, MUC1, MUC2, and MUC3. The results of these experiments demonstrate that CFPAC-1 cells contained 1.25 fold and 1.4 fold more HMG in the membrane and cytosolic fractions, however, secreted 4-fold more HMG into the medium compared to SW-1990 cells. The HMG of SW-1990 was found to be mucinous in nature and not proteoglycans, as it was not susceptible to hyalurinidase, heparinase and chondroitinase ABC. The HMG of CFPAC-1 was also predominantly (80%) mucinous but with small amounts of proteoglycans. mRNA and immunoblot analysis suggest that these CFPAC-1 and SW-1990 cells predominantly express MUC1 apomucin, small amounts of MUC2 apomucin, and no MUC3. Pulse chase labeling and immunoprecipitation of MUC1 type mucin using the 139H2 monoclonal antibody demonstrated that different sizes of mucin gene product were present in both cell lines, corresponding to the known length polymorphism of this mucin. Both T and Tn antigens were significantly higher in CFPAC-1 and SW-1990 cells as compared to sialosyl Tn antigen. These findings were associated with the increased activities of polypeptidyl N-acetylgalactosaminyl transferase and b1,3-galactosyltransferase. These investigations demonstrate for the first time that cystic fibrosis cells (CFPAC-1) secrete and synthesize high amounts of mucin which is associated with high levels of MUC1 mRNA, low levels of MUC2 mRNA and non detectable MUC3 mRNA.
Asunto(s)
Fibrosis Quística/metabolismo , Glicoproteínas de Membrana/biosíntesis , Mucinas/biosíntesis , Neoplasias Pancreáticas/metabolismo , Secuencia de Aminoácidos , Anticuerpos , Línea Celular , Condroitinasas y Condroitín Liasas , Secuencia de Consenso , Sondas de ADN , ADN Complementario , Epítopos/análisis , Expresión Génica , Glucosamina/metabolismo , Glicoproteínas/biosíntesis , Glicoproteínas/aislamiento & purificación , Liasa de Heparina , Humanos , Hialuronoglucosaminidasa , Immunoblotting , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/aislamiento & purificación , Datos de Secuencia Molecular , Mucina-1 , Mucinas/genética , Mucinas/aislamiento & purificación , Proteínas de Neoplasias/biosíntesis , Polisacárido Liasas , ARN Mensajero/análisis , ARN Mensajero/biosíntesis , Secuencias Repetitivas de Ácidos Nucleicos , TritioRESUMEN
The ability of activated T lymphocytes to penetrate the extracellular matrix and migrate to target tissues was found to be related to expression of a heparanase enzyme (Naparstek, Y., I. R. Cohen, Z. Fuks, and I. Vlodavsky. 1984. Nature (Lond.). 310:241-243; Savion, N., Z. Fuks, and I. Vlodavsky. 1984. J. Cell. Physiol. 118:169-176; Fridman, R., O. Lider, Y. Naparstek, Z. Fuks, I. Vlodavsky, and I. R. Cohen. 1987. J. Cell. Physiol. 130:85-92; Lider, O., J. Mekori, I. Vlodavsky, E. Baharav, Y. Naparstek, and I. R. Cohen, manuscript submitted for publication). We found previously that heparin molecules inhibited expression of T lymphocyte heparanase activity in vitro and in vivo, and administration of a low dose of heparin in mice inhibited lymphocyte traffic and delayed-type hypersensitivity reactions (Lider, O., J. Mekori, I. Vlodavsky, E. Baharav, Y. Naparstek, and I. R. Cohen, manuscript submitted for publication). We now report that treatment with commercial or chemically modified heparins at relatively low doses once daily (5 micrograms for mice and 20 micrograms for rats) led to inhibition of allograft rejection and the experimental autoimmune diseases adjuvant arthritis and experimental autoimmune encephalomyelitis. Higher doses of the heparins were less effective. The ability of chemically modified heparins to inhibit these immune reactions was associated with their ability to inhibit expression of T lymphocyte heparanase. There was no relationship to anticoagulant activity. Thus heparins devoid of anticoagulant activity can be effective in regulating immune reactions when used at appropriate doses.
Asunto(s)
Enfermedades Autoinmunes/tratamiento farmacológico , Supervivencia de Injerto/efectos de los fármacos , Heparina/uso terapéutico , Acetilación , Animales , Antígenos Bacterianos/inmunología , Artritis Experimental/tratamiento farmacológico , Artritis Experimental/inmunología , Enfermedades Autoinmunes/inmunología , Fenómenos Químicos , Química , Relación Dosis-Respuesta a Droga , Encefalomielitis Autoinmune Experimental/tratamiento farmacológico , Encefalomielitis Autoinmune Experimental/inmunología , Femenino , Heparina/administración & dosificación , Heparina/farmacología , Liasa de Heparina , Inmunización , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Mycobacterium tuberculosis/inmunología , Polisacárido Liasas/antagonistas & inhibidores , Ratas , Ratas Endogámicas Lew , Sulfatos , Linfocitos T/efectos de los fármacos , Linfocitos T/enzimología , Linfocitos T/inmunologíaRESUMEN
Proliferation of smooth muscle cells from the pulmonary arteries and aortas of fetal calves is inhibited by heparin in vitro. This effect is reversible and dose dependent. Comparisons with effects of other polysaccharides indicate that only extensively sulfated polysaccharides inhibit proliferation of smooth muscle cells but that specific structural features of heparin are required to achieve maximum effect. Heparin-Sepharose chromatography of medium containing fetal calf serum reduces the ability of that medium to promote growth of smooth muscle cells from fetal pulmonary arteries, suggesting that heparin may remove soluble growth factors in serum. However, inhibition of fetal pulmonary artery smooth muscle cell proliferation by heparin is identical in media supplemented either with serum prepared from fetal calf plasma, in which platelet-derived growth factor (PDGF) is not detectable, or with fetal calf serum, which contains relatively abundant PDGF (114 pg/ml). Thus, inhibition of fetal pulmonary artery smooth muscle cell proliferation by heparin is not mediated solely by decreased availability or activity of exogenous PDGF. These studies suggest that morphogenesis of the smooth muscle investment of the pulmonary arteries could be regulated by local production of heparin-like inhibitors of smooth muscle cell growth.
Asunto(s)
Heparina/farmacología , Músculo Liso Vascular/citología , Animales , Aorta , Sangre , Bovinos , División Celular/efectos de los fármacos , Células Cultivadas , Sulfatos de Condroitina/farmacología , Medios de Cultivo , Dermatán Sulfato/farmacología , Sulfato de Dextran , Dextranos/farmacología , Relación Dosis-Respuesta a Droga , Liasa de Heparina , Morfogénesis/efectos de los fármacos , Músculo Liso Vascular/embriología , Factor de Crecimiento Derivado de Plaquetas/farmacología , Polisacárido Liasas/farmacología , Arteria PulmonarRESUMEN
An unusual heparan sulfate was isolated from lobsters (Homarus americanus). The polysaccharide has a composition and properties intermediate to heparin and the more common heparan sulfates. The sulfate and D-glucuronic acid content is high, while anticoagulant activity is low. The major repeating unit appears to consist of D-glucuronic acid and D-glucosamine N-O-disulfate. Some N-acetyl groups are present, the content of L-iduronic acid O-sulfate is low, and monosulfated or nonsulfated disaccharide-repeating units (very common in heparan sulfates) appear to be very rare. The data obtained again emphasize the heterogeneity of heparan sulfates and the need for adequate characterization when dealing with unusual or unexplored sources.